• Home

  • About

  • Products

  • FAQs

  • Blog

  • Terms

  • Contact

  • More

    0

    © 2015 by Zenobia Therapeutics Inc

    3550 General Atomics Court Building 2 Suite 435  San Diego CA

    858-378-6031

    Erika@zenobiatherapeutics.com

    Maximizing your time at the Fragment-Based Lead Discovery Conference San Diego, California, October 7th-10th 2018

    October 5, 2018

    I-Corps at the NIH: What we learned and how it can help you obtain grants and grow your business!

    September 20, 2018

    Five Easy Steps to Submitting a New Grant

    August 17, 2018

    How does Zenobia design it's shape diverse mixtures?

    July 27, 2017

    What is Crystallographic Screening and Why is it Making a Comeback?

    July 20, 2017

    Drugability Series, Part 1

    April 6, 2017

    Diversity Series, Part 3

    February 27, 2017

    Diversity Series, Part 2

    February 1, 2017

    Diversity Series, Part 1

    September 23, 2016

    GoT Frags?

    August 3, 2016

    Please reload

    Recent Posts

    Diversity Series, Part 1

    September 23, 2016

    GoT Frags?

    August 3, 2016

    Diversity Series, Part 3

    February 27, 2017

    1/3
    Please reload

    Featured Posts

    How does Zenobia design it's shape diverse mixtures?

    July 27, 2017

    Why Screen as Mixtures?

     

    In many cases, it is much more efficient to screen as mixtures because it pares down the dataset to a manageable range. One uses screening mixtures by soaking the crystal in a cocktail with multiple ligands. The secret to designing the proper mixture is to ensure that each ligand in the cocktail is differentiable from the other ligands, even at low resolutions. Express-Zen-Core288™ has a very high shape diversity, making it possible to group into shape diverse mixtures that can be distinguished at 2.7Å-3.0Å. 

     

    How Does Zenobia Make it's Mixtures?

     

    Zenobia's mixtures for crystallographic screening contain up to 6 compounds that are highly shape diverse permitting identification of the hit from the shape of the electron density map (Nienaber et al., 2000). For those that are not limited by crystals or beamtime, mixtures of 3 or single compound screening kits are also available for crystallography. Sample mixtures of 6 are depicted below.

                     Examples of three of the shape diverse mixtures of 6 in Zen-Core288™.

     

     

    To prepare these mixtures, the Express-ZenCore288™ collection was sorted based upon Murcko core and further grouped by Murcko cores with the same shape (e.g. benzyl and pyrimidyl). The collection contains 8 brominated and 1 iodinated compounds which were placed in separate mixtures to further enhance diversity. Express-Zen-Core288™ has a high core/shape diversity built in to increase the likelihood of a hit. This characteristic allows definition of highly diverse mixtures.

     

    How does Zenobia Validate its Mixtures?

     

    To validate the mixtures, 3D coordinates were generated, energy minimized and sorted into the 48 mixtures of six. PDB structures were overlaid and visually examined to ensure the compounds could be distinguished by visual examination. These PDB files are available as part of the Express-Core288™ package to enable rapid structure determination.

     

    To learn more about these products and obtain detailed information like PDB files, SOPs, and compound lists, visit this page!

     

    References:

    Nienaber, Vicki et. al (2000). Discovering novel ligands for macromolecules using X-ray crystallographic screening. Nat Biotechnol. 2000 Oct;18(10):1105-8.

    Tags:

    X-ray Crystallography

    ligand

    Xray

    Xray Crystallography

    chemical

    Fragment Based Lead Discovery

    Zenobia Therapeutics

    Science

    shape diverse

    shape diverse mixtures

    Crystallography

    biochemical

    Research

    Zenobia

    Drug Discovery

    FBLD

    Structural Biology

    X-ray

    Screening

    Zenobia Fragments

    Crystallographic Screen

    ZEN-CORE 288

    Core 288 Xray

    Please reload

    Follow Us

    Core 288 Xray

    Crystal Screening

    Crystallographic Screen